Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Kidney Disease, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT06501651
What this trial is testing

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Who this might be right for
Essential HypertensionType 2 DiabetesNephropathy
Sichuan Academy of Medical Sciences 297
Not applicableStudy completedNCT05631119
What this trial is testing

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseDiabetes Type 2Chronic Kidney Diseases+1 more
Sanguine Biosciences 40
Large-scale testing (Phase 3)Study completedNCT01087502
What this trial is testing

Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 241
Not applicableUnknownNCT04119167
What this trial is testing

Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians

Who this might be right for
Diabetes Mellitus, Type 2Diabetic PolyneuropathyDiabetic Nephropathies
Chang Gung Memorial Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00734253
What this trial is testing

Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes

Who this might be right for
Diabetic Nephropathy
NephroGenex, Inc. 317
Post-approval studies (Phase 4)Study completedNCT00272831
What this trial is testing

The Use of Cilostazol in Patients With Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Complications
Chinese University of Hong Kong 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04573920
What this trial is testing

Atrasentan in Patients With Proteinuric Glomerular Diseases

Who this might be right for
IgA NephropathyFocal Segmental GlomerulosclerosisAlport Syndrome+3 more
Novartis Pharmaceuticals 103
Not applicableLooking for participantsNCT03865914
What this trial is testing

Correlation Study Between Clinical Phenotype and Pathology of Type 2 Diabetic Nephropathy

Who this might be right for
Diabetic Kidney Disease
Chinese PLA General Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT00274118
What this trial is testing

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Who this might be right for
HypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim 250
Not applicableEnded earlyNCT00448526
What this trial is testing

Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Kanazawa Medical University
Not applicableEnrolling By InvitationNCT07456774
What this trial is testing

A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China

Who this might be right for
Type 2 Diabetes
Novo Nordisk A/S 100,000
Post-approval studies (Phase 4)Study completedNCT04238702
What this trial is testing

Renohemodynamic Effects of Combined empagliflOzin and LosARtan

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Kidney Disease
Amsterdam UMC, location VUmc 24
Testing effectiveness (Phase 2)WithdrawnNCT00398892
What this trial is testing

The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
University of Edinburgh
Not applicableStudy completedNCT05530356
What this trial is testing

Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study

Who this might be right for
Type 2 DiabetesDiabetes Type 2Diabetic Nephropathies+4 more
University of Colorado, Denver 57
Post-approval studies (Phase 4)Ended earlyNCT03152084
What this trial is testing

The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.

Who this might be right for
Diabetes Mellitus, Type 2Kidney Function Tests
AstraZeneca 24
Not applicableUnknownNCT06222476
What this trial is testing

Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.

Who this might be right for
Diabetic Nephropathy Type 2
Yan Bi 106
Testing effectiveness (Phase 2)UnknownNCT04143412
What this trial is testing

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

Who this might be right for
Diabetic Nephropathy Type 2Microalbuminuria Due to Type 2 Diabetes Mellitus
Beni-Suef University 75
Large-scale testing (Phase 3)Ended earlyNCT01351675
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 2,185
Not applicableStudy completedNCT00715481
What this trial is testing

Renal Insufficiency And Cardiovascular Events

Who this might be right for
Cardiovascular Disease
Diabetic Nephropathy Study Group 15,628
Not applicableUnknownNCT03413215
What this trial is testing

Effects of Multidisciplinary Intensive Targeted Care in Improving Diabetes Outcomes: a Pilot Study in Singapore

Who this might be right for
Diabetes Mellitus, Type 2Diabetic NephropathyHypertension
Changi General Hospital 50
Next Page